Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

MUC5A rabbit pAb

Domain: The cysteine residues in the Cys-rich subdomain repeats are not involved in disulfide bonding. function: Gel-forming glycoprotein of gastric and respiratoy tract epithelia that protects the mucosa from infection and chemical damage by binding to inhaled microrganisms and particules that are subsequently removed by the mucocilary system. PTM: C-, O- and N-glycosylated. O-glycosylated on the Thr-/Ser-rich tandem repeats. C-mannosylation in the Cys-rich subdomains may be required for proper folding of these regions and for export from the endoplasmic reticulum during biosynthesis. PTM: Proteolytic cleavage in the C-terminal is initiated early in the secretory pathway and does not involve a serine protease. The extent of cleavage is increased in the acidic parts of the secretory pathway. Cleavage generates a reactive group which could link the protein to a primary amide. similarity: Contains 1 CTCK (C-terminal cystine knot-like) domain. similarity: Contains 2 VWFC domains. similarity: Contains 4 VWFD domains. subunit: Multimeric. Interacts with H. pylori in the gastric epithelium, Barrett's esophagus as well as in gastric metaplasia of the duodenum (GMD). tissue specificity: Highly expressed in surface mucosal cells of respiratory tract and stomach epithelia. Overexpressed in a number of carcinomas. Also expressed in Barrett's esophagus epithelium and in the proximal duodenum.

Product Specifications

Background

Domain:The cysteine residues in the Cys-rich subdomain repeats are not involved in disulfide bonding., function:Gel-forming glycoprotein of gastric and respiratoy tract epithelia that protects the mucosa from infection and chemical damage by binding to inhaled microrganisms and particules that are subsequently removed by the mucocilary system., PTM:C-, O- and N-glycosylated. O-glycosylated on the Thr-/Ser-rich tandem repeats. C-mannosylation in the Cys-rich subdomains may be required for proper folding of these regions and for export from the endoplasmic reticulum during biosynthesis., PTM:Proteolytic cleavage in the C-terminal is initiated early in the secretory pathway and does not involve a serine protease. The extent of cleavage is increased in the acidic parts of the secretory pathway. Cleavage generates a reactive group which could link the protein to a primary amide., similarity:Contains 1 CTCK (C-terminal cystine knot-like) domain., similarity:Contains 2 VWFC domains., similarity:Contains 4 VWFD domains., subunit:Multimeric. Interacts with H.pylori in the gastric epithelium, Barrett's esophagus as well as in gastric metaplasia of the duodenum (GMD) ., tissue specificity:Highly expressed in surface mucosal cells of respiratory tract and stomach epithelia. Overexpressed in a number of carcinomas. Also expressed in Barrett's esophagus epithelium and in the proximal duodenum.

UniProt

P98088

Swiss Prot

P98088

Reactivity

Human; Rat; Mouse

Immunogen

Synthesized peptide derived from human protein . at AA range: 4400-4480

Clonality

Polyclonal

Source

Rabbit

Applications

IHC; IF

Concentration

1 mg/ml

Dilution

IHC-p 1:50-300

Molecular Weight

553kD

Storage Conditions

-20°C/1 year

Observed Molecular Weight

553kD

Fragment

IgG

Subcellular Location

Secreted .

Available Sizes

More Discoveries

Explore Other Products

Browse additional items from our catalog

N- (2,5-diaza-2- (2- (2-methylphenyl) -2-oxoethyl) -3-oxo-6-phenylbicyclo[5.4.0]undeca-1 (7),5,8,10-tetraen-4-yl) ((3,5-dimethylphenyl) amin o) formamide
WWC88271-01 10 mg

N- (2,5-diaza-2- (2- (2-methylphenyl) -2-oxoethyl) -3-oxo-6-phenylbicyclo[5.4.0]undeca-1 (7),5,8,10-tetraen-4-yl) ((3,5-dimethylphenyl) amin o) formamide

Sign In for Pricing
View Details
N- (2,5-diaza-2- (2- (2-methylphenyl) -2-oxoethyl) -3-oxo-6-phenylbicyclo[5.4.0]undeca-1 (7),5,8,10-tetraen-4-yl) ((3,5-dimethylphenyl) amin o) formamide
WWC88271-02 25 mg

N- (2,5-diaza-2- (2- (2-methylphenyl) -2-oxoethyl) -3-oxo-6-phenylbicyclo[5.4.0]undeca-1 (7),5,8,10-tetraen-4-yl) ((3,5-dimethylphenyl) amin o) formamide

Sign In for Pricing
View Details
N- (2,5-diaza-2- (2- (2-methylphenyl) -2-oxoethyl) -3-oxo-6-phenylbicyclo[5.4.0]undeca-1 (7),5,8,10-tetraen-4-yl) ((3,5-dimethylphenyl) amin o) formamide
WWC88271-03 50 mg

N- (2,5-diaza-2- (2- (2-methylphenyl) -2-oxoethyl) -3-oxo-6-phenylbicyclo[5.4.0]undeca-1 (7),5,8,10-tetraen-4-yl) ((3,5-dimethylphenyl) amin o) formamide

Sign In for Pricing
View Details
N- (2,5-diaza-2- (2- (2-methylphenyl) -2-oxoethyl) -3-oxo-6-phenylbicyclo[5.4.0]undeca-1 (7),5,8,10-tetraen-4-yl) ((3,5-dimethylphenyl) amin o) formamide
WWC88271-04 100 mg

N- (2,5-diaza-2- (2- (2-methylphenyl) -2-oxoethyl) -3-oxo-6-phenylbicyclo[5.4.0]undeca-1 (7),5,8,10-tetraen-4-yl) ((3,5-dimethylphenyl) amin o) formamide

Sign In for Pricing
View Details
N- (2,5-diaza-2- (2- (2-methylphenyl) -2-oxoethyl) -3-oxo-6-phenylbicyclo[5.4.0]undeca-1 (7),5,8,10-tetraen-4-yl) ((3,5-dimethylphenyl) amin o) formamide
WWC88271-05 250 mg

N- (2,5-diaza-2- (2- (2-methylphenyl) -2-oxoethyl) -3-oxo-6-phenylbicyclo[5.4.0]undeca-1 (7),5,8,10-tetraen-4-yl) ((3,5-dimethylphenyl) amin o) formamide

Sign In for Pricing
View Details
CBR4
CSB-CL850803HU2 10 μg Plasmid + 200 μL Glycerol

CBR4

Sign In for Pricing
View Details